These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 6713473)

  • 21. [Ergometric and clinical results of treating coronary disease with isosorbide dinitrate and verapamil].
    Pozenel H
    Med Welt; 1981 Jun; 32(24):988-92. PubMed ID: 7253907
    [No Abstract]   [Full Text] [Related]  

  • 22. [Drug therapy of coronary heart disease. Comparative effects of nifedipine and isosorbide dinitrate].
    Böhm C; Christl HL; Wald G
    Med Welt; 1982 Sep; 33(36):1242-4. PubMed ID: 7132675
    [No Abstract]   [Full Text] [Related]  

  • 23. [Use of isonit (nitrosorbide) in the treatment of ischemic heart disease].
    Zamotaev IP; Venediktova MG; Lozinskiĭ LG; Sandomirskiĭ BL
    Klin Med (Mosk); 1986 Jun; 64(6):28-33. PubMed ID: 3747432
    [No Abstract]   [Full Text] [Related]  

  • 24. [Changes in the efficiency of the left heart ventricle during treatment with metipranolol (Trimepranol Spofa)].
    Smíd J; Hůla J; Kubín Z
    Vnitr Lek; 1983 Apr; 29(4):325-31. PubMed ID: 6135276
    [No Abstract]   [Full Text] [Related]  

  • 25. [Treatment of coronary heart disease. Oxycardin retard in simultaneously existing arterial hypertension].
    Hoffmann J
    Fortschr Med; 1983 Apr; 101(16):764-7. PubMed ID: 6852752
    [No Abstract]   [Full Text] [Related]  

  • 26. The effect of isosorbide dinitrate following experimental coronary occlusion.
    Meester WS; Van Harn GL
    Am Heart J; 1976 Aug; 92(2):217-22. PubMed ID: 941833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of parasympathetic blockade on ischemic threshold in patients with exercise-induced myocardial ischemia.
    Marraccini P; Orsini E; Nassi G; L'Abbate A
    Am J Cardiol; 1991 Aug; 68(5):539-42. PubMed ID: 1872284
    [No Abstract]   [Full Text] [Related]  

  • 28. [Value of Iso Mack Retard in the treatment of coronary disease].
    Zminkowska U; Markiewicz M
    Wiad Lek; 1984 Apr; 37(7):496-500. PubMed ID: 6385487
    [No Abstract]   [Full Text] [Related]  

  • 29. A comparison between the effects of diltiazem and isosorbide dinitrate on digoxin pharmacodynamics and kinetics in the treatment of patients with chronic ischemic heart failure.
    Mahgoub AA; El-Medany AH; Abdulatif AS
    Saudi Med J; 2002 Jun; 23(6):725-31. PubMed ID: 12070557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Coronary disease. Clinical experience with a new active substance combination].
    Bouzo H
    Med Welt; 1977 Dec; 28(49):2001-7. PubMed ID: 340839
    [No Abstract]   [Full Text] [Related]  

  • 31. [The effect of changes in stroke volume on QT dispersion during long-term DDD and VVI pacing].
    Lelakowski J; Majewski J; Bednarek J; Szczepkowski J; Machejek J
    Przegl Lek; 2001; 58(3):111-6. PubMed ID: 11475854
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isosorbide dinitrate in the treatment of silent myocardial ischaemia in patients after myocardial infarction: an open pilot study.
    Moczurad KW; Dubiel JP; Grodecki JK; Curylo AM
    Eur J Clin Pharmacol; 1989; 37(6):621-2. PubMed ID: 2612559
    [No Abstract]   [Full Text] [Related]  

  • 33. [Hemodynamic changes during treatment with isodinit, sectral, stenopril and kratemon].
    Stankusheva G; Draganov V; Manolov P
    Vutr Boles; 1987; 26(2):33-8. PubMed ID: 3604194
    [No Abstract]   [Full Text] [Related]  

  • 34. Characteristics and clinical significance of silent myocardial ischemia during ambulatory electrocardiographic monitoring in patients with ischemic heart disease.
    Kohya T; Tomita F; Yasuda H
    Jpn J Med; 1990; 29(6):671-2. PubMed ID: 1983201
    [No Abstract]   [Full Text] [Related]  

  • 35. [Treatment of coronary insufficiency. Comparative study on the effect of a nitro compound (isosorbidedinitrate), a beta sympatholytic (bupranolol) and a drug combination (oxycardin)].
    Philipp R; Kutscha W
    Med Welt; 1980 May; 31(21):817-20. PubMed ID: 7392937
    [No Abstract]   [Full Text] [Related]  

  • 36. [Longterm effect and maintenance therapy with cutaneous isosorbide dinitrate in patients with coronary heart disease (author's transl)].
    Brunner D; Weisbord J; Meshulam N; Margulis S
    MMW Munch Med Wochenschr; 1980 May; 122(21):801-6. PubMed ID: 6771600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differences in the antiischaemic effects of molsidomine and isosorbide dinitrate.
    Jost S
    Eur Heart J; 1992 May; 13(5):720. PubMed ID: 1618218
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparison of sublingual nitroglycerine and isosorbide dinitrate ointment by radionuclide ventriculography.
    Lele RD; Divgi CR; Bhonsle US
    J Assoc Physicians India; 1981 Jun; 29(6):447-56. PubMed ID: 6798013
    [No Abstract]   [Full Text] [Related]  

  • 39. [Determination of the effect of a new anti-anginal drug, isosorbide dinitrate tape (TY0081), by Holter electrocardiography].
    Kohya T; Itoh K; Ando J; Tomita K; Yasuda H
    Kokyu To Junkan; 1983 Feb; 31(2):181-7. PubMed ID: 6867483
    [No Abstract]   [Full Text] [Related]  

  • 40. [Sorbonit in coronary disease].
    Chojnowski JR; Adamska-Dyniewska H; Florczak H; Chojnowska-Jezierska J; Mockallo T
    Pol Tyg Lek; 1968 May; 23(21):797-9. PubMed ID: 4875472
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.